• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳头肌对肥厚型心肌病左心室重要参数心脏磁共振成像分析的影响。

Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy.

作者信息

Gommans D H F, Bakker J, Cramer G E, Verheugt F W A, Brouwer M A, Kofflard M J M

机构信息

Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Department of Radiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.

出版信息

Neth Heart J. 2016 May;24(5):326-31. doi: 10.1007/s12471-016-0805-y.

DOI:10.1007/s12471-016-0805-y
PMID:26914916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4840113/
Abstract

PURPOSE

The use of cardiac magnetic resonance (CMR) analysis has increased in patients with hypertrophic cardiomyopathy (HCM). Quantification of left ventricular (LV) measures will be affected by the inclusion or exclusion of the papillary muscles as part of the LV mass, but the magnitude of effect and potential consequences are unknown.

METHODS

We performed Cine-CMR in (1) clinical HCM patients (n = 55) and (2) subclinical HCM mutation carriers without hypertrophy (n = 14). Absolute and relative differences in LV ejection fraction (EF) and mass were assessed between algorithms with and without inclusion of the papillary muscles.

RESULTS

Papillary muscle mass in group 1 was 6.6 ± 2.5 g/m(2) and inclusion of the papillary muscles resulted in significant relative increases in LVEF of 4.5 ± 1.8 % and in LV mass of 8.7 ± 2.6 %. For group 2 these figures were 4.0 ± 0.9 g/m(2), 3.8 ± 1.0 % and 9.5 ± 1.8 %, respectively. With a coefficient of variation of 4 %, this 9 % difference in LV mass during CMR follow-up will be considered a change, while in fact the exact same mass may have been assessed according to two different algorithms.

CONCLUSIONS

In clinical HCM patients, CMR quantification of important LV measures is significantly affected by inclusion or exclusion of the papillary muscles. In relative terms, the difference was similar in subjects without hypertrophy. This underscores a general need for a uniform approach in CMR image analysis.

摘要

目的

肥厚型心肌病(HCM)患者中使用心脏磁共振(CMR)分析的情况有所增加。左心室(LV)测量的量化会受到将乳头肌纳入或排除在LV质量计算范围内的影响,但这种影响的程度和潜在后果尚不清楚。

方法

我们对(1)临床HCM患者(n = 55)和(2)无肥厚的亚临床HCM突变携带者(n = 14)进行了电影CMR检查。评估了包含和不包含乳头肌的算法之间LV射血分数(EF)和质量的绝对和相对差异。

结果

第1组的乳头肌质量为6.6±2.5 g/m²,将乳头肌纳入计算导致LVEF相对显著增加4.5±1.8%,LV质量相对显著增加8.7±2.6%。对于第2组,这些数字分别为4.0±0.9 g/m²、3.8±1.0%和9.5±1.8%。由于变异系数为4%,CMR随访期间LV质量9%的差异将被视为一种变化,而实际上根据两种不同算法评估的可能是完全相同的质量。

结论

在临床HCM患者中,CMR对重要LV测量的量化受到乳头肌纳入或排除的显著影响。相对而言,在无肥厚的受试者中差异相似。这突出了CMR图像分析中统一方法的普遍需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4033/4840113/58de61b48034/12471_2016_805_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4033/4840113/59960431b247/12471_2016_805_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4033/4840113/58de61b48034/12471_2016_805_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4033/4840113/59960431b247/12471_2016_805_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4033/4840113/58de61b48034/12471_2016_805_Fig2_HTML.jpg

相似文献

1
Impact of the papillary muscles on cardiac magnetic resonance image analysis of important left ventricular parameters in hypertrophic cardiomyopathy.乳头肌对肥厚型心肌病左心室重要参数心脏磁共振成像分析的影响。
Neth Heart J. 2016 May;24(5):326-31. doi: 10.1007/s12471-016-0805-y.
2
Effect of papillary muscles and trabeculae on left ventricular measurement using cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中乳头肌和小梁对使用心血管磁共振成像测量左心室的影响。
Korean J Radiol. 2015 Jan-Feb;16(1):4-12. doi: 10.3348/kjr.2015.16.1.4. Epub 2015 Jan 9.
3
Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.肥厚型心肌病患者左心室流出道梗阻与左心室形态的关系:一项心脏磁共振成像研究。
Arch Cardiovasc Dis. 2013 Aug-Sep;106(8-9):440-7. doi: 10.1016/j.acvd.2013.05.002. Epub 2013 Jul 29.
4
Impact of papillary and trabecular muscles on quantitative analyses of cardiac function in hypertrophic cardiomyopathy.肥厚型心肌病中心房功能定量分析中乳头肌和小梁肌的影响。
J Magn Reson Imaging. 2009 Nov;30(5):1197-202. doi: 10.1002/jmri.21958.
5
Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.肥厚型梗阻性心肌病患者心肌结构和功能的变化:SEQUOIA-HCM 心脏磁共振子研究。
J Am Coll Cardiol. 2024 Nov 5;84(19):1806-1817. doi: 10.1016/j.jacc.2024.08.015. Epub 2024 Sep 1.
6
Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.肥厚型心肌病中基底间隔纤维化与左心室流出道梗阻的关系:心脏磁共振分析的见解
Int J Cardiovasc Imaging. 2016 Apr;32(4):613-20. doi: 10.1007/s10554-015-0806-8. Epub 2015 Nov 20.
7
Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction.左心室乳头肌和小梁是心脏磁共振成像容积测量的重要决定因素:对晚期收缩功能障碍患者临床标准的影响。
Int J Cardiol. 2008 Jun 6;126(3):359-65. doi: 10.1016/j.ijcard.2007.04.179. Epub 2007 Aug 14.
8
Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.斯皮里托-马龙超声心动图评分:肥厚型心肌病患者形态学和生理学评估的一个指标。
Echocardiography. 2014 Jul;31(6):708-15. doi: 10.1111/echo.12471. Epub 2014 Jan 24.
9
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.肥胖及其与肥厚型心肌病表型和临床过程的关系。
J Am Coll Cardiol. 2013 Jul 30;62(5):449-57. doi: 10.1016/j.jacc.2013.03.062. Epub 2013 Apr 30.
10
Papillary and Trabecular Muscles Have Substantial Impact on Quantification of Left Ventricle in Patients with Hypertrophic Obstructive Cardiomyopathy.乳头肌和小梁肌对肥厚性梗阻性心肌病患者左心室定量分析有重大影响。
Diagnostics (Basel). 2022 Aug 22;12(8):2029. doi: 10.3390/diagnostics12082029.

引用本文的文献

1
The Role of Cardiac Magnetic Resonance Imaging in the Management of Hypertrophic Cardiomyopathy.心脏磁共振成像在肥厚型心肌病管理中的作用
J Cardiovasc Dev Dis. 2025 May 15;12(5):189. doi: 10.3390/jcdd12050189.
2
Comparative Study of 2D-Cine and 3D-wh Volumetry: Revealing Systemic Error of 2D-Cine Volumetry.二维电影成像与三维全容积成像的比较研究:揭示二维电影成像容积测量的系统误差
Diagnostics (Basel). 2023 Oct 10;13(20):3162. doi: 10.3390/diagnostics13203162.
3
Papillary and Trabecular Muscles Have Substantial Impact on Quantification of Left Ventricle in Patients with Hypertrophic Obstructive Cardiomyopathy.

本文引用的文献

1
Effect of papillary muscles and trabeculae on left ventricular measurement using cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中乳头肌和小梁对使用心血管磁共振成像测量左心室的影响。
Korean J Radiol. 2015 Jan-Feb;16(1):4-12. doi: 10.3348/kjr.2015.16.1.4. Epub 2015 Jan 9.
2
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial.血管紧张素 II 受体阻滞剂氯沙坦治疗肥厚型心肌病的疗效和安全性:INHERIT 随机、双盲、安慰剂对照试验。
Lancet Diabetes Endocrinol. 2015 Feb;3(2):123-31. doi: 10.1016/S2213-8587(14)70241-4. Epub 2014 Dec 19.
3
乳头肌和小梁肌对肥厚性梗阻性心肌病患者左心室定量分析有重大影响。
Diagnostics (Basel). 2022 Aug 22;12(8):2029. doi: 10.3390/diagnostics12082029.
4
Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR.应用 4D 流磁共振喷射轨迹法直接定量分析肥厚型心肌病的二尖瓣反流:与传统磁共振比较的评估。
J Cardiovasc Magn Reson. 2021 Dec 6;23(1):138. doi: 10.1186/s12968-021-00828-y.
5
Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.基于心脏磁共振的标志物对肥厚型心肌病患者的预后意义。
Int J Cardiovasc Imaging. 2021 Jun;37(6):2027-2036. doi: 10.1007/s10554-021-02165-8. Epub 2021 Feb 8.
6
Variation in left ventricular cardiac magnetic resonance normal reference ranges: systematic review and meta-analysis.左心室心脏磁共振正常参考范围的变化:系统评价和荟萃分析。
Eur Heart J Cardiovasc Imaging. 2021 Apr 28;22(5):494-504. doi: 10.1093/ehjci/jeaa089.
7
Simulation of the Perfusion of Contrast Agent Used in Cardiac Magnetic Resonance: A Step Toward Non-invasive Cardiac Perfusion Quantification.心脏磁共振成像中造影剂灌注的模拟:迈向无创心脏灌注定量的一步。
Front Physiol. 2019 Mar 14;10:177. doi: 10.3389/fphys.2019.00177. eCollection 2019.
8
The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.充满挑战的灰色地带:心脏磁共振成像的运动指标可区分肥厚型心肌病与运动员心脏。
PLoS One. 2019 Feb 14;14(2):e0211624. doi: 10.1371/journal.pone.0211624. eCollection 2019.
9
Quantification of mitral regurgitation in patients with hypertrophic cardiomyopathy using aortic and pulmonary flow data: impacts of left ventricular outflow tract obstruction and different left ventricular segmentation methods.应用主动脉和肺血流数据对肥厚型心肌病患者二尖瓣反流进行定量评估:左心室流出道梗阻和不同左心室分段方法的影响。
J Cardiovasc Magn Reson. 2017 Dec 21;19(1):105. doi: 10.1186/s12968-017-0417-8.
10
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.法布里病酶替代疗法长期疗效的回顾性研究:预后因素分析
PLoS One. 2017 Aug 1;12(8):e0182379. doi: 10.1371/journal.pone.0182379. eCollection 2017.
Ex vivo cardiovascular magnetic resonance measurements of right and left ventricular mass compared with direct mass measurement in excised hearts after transplantation: a first human SSFP comparison.
移植后离体心脏中右心室和左心室质量的体外心血管磁共振测量与直接质量测量的比较:首次人体稳态自由感应衰减序列比较
J Cardiovasc Magn Reson. 2014 Oct 1;16(1):74. doi: 10.1186/s12968-014-0074-0.
4
Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: Discrepancy between cardiac magnetic resonance imaging and 2D echocardiography.评估适合 ICD 治疗的患者的左心室射血分数:心脏磁共振成像与二维超声心动图的差异。
Neth Heart J. 2014 Oct;22(10):449-55. doi: 10.1007/s12471-014-0594-0.
5
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).2014年欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗指南:欧洲心脏病学会(ESC)肥厚型心肌病诊断和治疗工作组
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
6
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
7
Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy.延迟钆增强心血管磁共振成像在肥厚型心肌病危险分层中的作用
Heart. 2014 Dec;100(23):1851-8. doi: 10.1136/heartjnl-2013-305471. Epub 2014 Jun 24.
8
Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.氯沙坦对非梗阻性肥厚型心肌病患者左心室肥厚和纤维化的影响。
JACC Heart Fail. 2013 Dec;1(6):480-7. doi: 10.1016/j.jchf.2013.09.001. Epub 2013 Oct 24.
9
Relation of highly sensitive cardiac troponin T in hypertrophic cardiomyopathy to left ventricular mass and cardiovascular risk.肥厚型心肌病中心脏肌钙蛋白 T 高敏与左心室质量和心血管风险的关系。
Am J Cardiol. 2014 Apr 1;113(7):1240-5. doi: 10.1016/j.amjcard.2013.12.033. Epub 2014 Jan 16.
10
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.心血管磁共振标准化图像解读和后处理:心血管磁共振学会(SCMR)董事会后处理标准化工作组。
J Cardiovasc Magn Reson. 2013 May 1;15(1):35. doi: 10.1186/1532-429X-15-35.